生殖系细胞基因编辑的法律规制进路

Legal Regulatory Approach of Germline Cell Gene Editing

生殖系细胞基因编辑是一项具有潜在革命性的技术,可用于治疗和预防许多遗传性疾病,如囊性纤维化和血友病。尽管这项技术在医学界和公众中引起了广泛的讨论,但其法律规制进路尚未完全确定。通过归纳学习国外相关法律法规,分析总结中国法律现状,探讨社会平等、个体主体性和代际权利三个伦理话题。结合现行的法律规范和相关伦理考量,针对法律可操作性较弱、立法界限模糊、伦理审查机制不够完善等问题提出了生殖系细胞基因编辑的法律规制进路。为了更好地确保技术能够在排除风险的前提下造福人类,提出以下建议:需要在明确立法原则的基础上,制定专门法予以调整并以此为指导完善生殖系细胞基因编辑的伦理审查机制。希望能够通过深入研究,推动生殖系细胞基因编辑技术的进展,为制定相关的法律和伦理政策提供有益参考。

Germline cell gene editing is a potentially revolutionary technology that can be used to treat and prevent many genetic diseases,such as cystic fibrosis and hemophilia.Although this technology has aroused widespread discussion in the medical community and the public,its legal regulatory approach has not yet been fully determined.By summarizing and studying the experience of relevant foreign laws and regulations,this paper analyzed and summarized the current legal situation in China,and explored three ethical topics of social equality,individual subjectivity,and intergenerational rights.Combining the existing legal norms and relevant ethical considerations,the legal regulatory approach for germline cell gene editing was proposed in view of the weak operability of the law,the blurred boundaries of the legislation,and the insufficiently perfect ethical review mechanism.To better ensure that the technology can benefit mankind on the premise of eliminating risks,the following suggestions were put forward:a specialized law should be formulated based on clear legislative principles to adjust and guide the improvement of the ethical review mechanism of germline cell gene editing.It is hoped that promoting the progress of germline cell gene editing technology through in-depth research,and providing useful reference for the formulation of relevant laws and ethical policies.